Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis
Critical Reviews in Oncology/Hematology(2020)
摘要
•Immunotherapy significantly improves overall survival and response rate of patients with head and neck squamous cell carcinoma.•Immunotherapy is most beneficial for patients with HPV and PD-L1 positive head and neck tumors.•Immunotherapy results in lower rates of treatment-related adverse events and toxicity.
更多查看译文
关键词
Head and neck squamous cell carcinoma,Immunotherapy,Human papillomavirus,Programmed death-ligand 1,Toxicity,Meta-analysis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要